Microsatellite Instability in the Tumor Microenvironment: The Role of Inflammation and the Microbiome
Cancer Medicine · 2025
DOI: 10.1002/cam4.70603 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2025. Verfasst von Elizabeth Vargas-Castellanos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Mayor-Mederi, Universidad del Rosario, Bogotá, Colombia. Hauptthemen laut MEDLINE: Tumor Microenvironment, Microsatellite Instability, Neoplasms, Inflammation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Universitario Mayor Méderi.
Abstract (Originalsprache)
Background
Microsatellite instability (MSI) is a hallmark of DNA mismatch repair (MMR) deficiency that leads to genomic instability and increased cancer risk. The tumor microenvironment (TME) significantly influences MSI‐driven tumorigenesis, and emerging evidence points to a critical role of the microbiome in shaping this complex interplay.
Methods
This review comprehensively examines the existing literature on the intricate relationship between MSI, microbiome, and cancer development, with a particular focus on the impact of microbial dysbiosis on the TME.
Results
MSI‐high tumors exhibited increased immune cell infiltration owing to the generation of neoantigens. However, immune evasion mechanisms such as PD‐1/CTLA‐4 upregulation limit the efficacy of immune checkpoint inhibitors (ICIs) in a subset of patients. Pathobionts, such as Fusobacterium nucleatum and Bacteroides fragilis, contribute to MSI through the production of genotoxins, further promoting inflammation and oxidative stress within the TME.
Conclusions
The microbiome profoundly affects MSI‐driven tumorigenesis. Modulation of the gut microbiota through interventions such as fecal microbiota transplantation, probiotics, and dietary changes holds promise for improving ICI response rates. Further research into cancer pharmacomicrobiomics, investigating the interplay between microbial metabolites and anticancer therapies, is crucial for developing personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Universitario Mayor-Mederi, Universidad del Rosario, Bogotá, Colombia.
- Facultad de Ciencias de la Salud, Universidad Colegio Mayor de Cundinamarca, Bogotá, Colombia.
ORCID-Profile: Elizabeth Vargas-Castellanos, Andrés Rincón-Riveros
Förderung
- Hospital Universitario Mayor Méderi
Zitieren
APA
Vargas-Castellanos, E., & Rincón-Riveros, A. (2025). Microsatellite Instability in the Tumor Microenvironment: The Role of Inflammation and the Microbiome. Cancer Medicine. https://doi.org/10.1002/cam4.70603
Vancouver
Vargas-Castellanos E, Rincón-Riveros A. Microsatellite Instability in the Tumor Microenvironment: The Role of Inflammation and the Microbiome. Cancer Medicine. 2025. doi:10.1002/cam4.70603
BibTeX
@article{VargasCastellanos2025,
author = {Vargas-Castellanos, Elizabeth and Rincón-Riveros, Andrés},
title = {Microsatellite Instability in the Tumor Microenvironment: The Role of Inflammation and the Microbiome},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70603}
}
EUVIMED